PATENT CLAIM ANALYSIS

Application Number: 15771077
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "237500"]

Abstract:
Described herein, inter alia, are compositions and methods for treating or preventing obesity and using the same.

Claim (Index 1):
A compound of Formula (I): wherein the dotted lines between C 1  and C 2 , C 2  and R 3 , C 3  and R 4 , C 5  and C 6 , C 5  and C 7 , C 1  and C 6 , and C 3  and C 4  indicate that a single or double bond may be present, as valence permits; R 1  is \u2014CN, \u2014COOH, \u2014COOCH 2 CH 3 , \u2014CONHR 5 , \u2014CONR 5 R 5 , \u2014COOR 5 , \u2014COOCH 3 , \u2014CH 2 NR 5 R 5 , \u2014CH 2 OCONR 5 R 5 , \u2014CH 2 NR 5 COOR 5 , \u2014CH 2 R 5 , \u2014CH 2 NR 5 CONR 5 R 5 , \u2014CH 2 OH, \u2014CH 2 OR 5 , alkylsulfate, alkylsulfonate, alkylphosphate, \u2014CH 2 OSO 3 R 5 , \u2014CH 2 OSO 2 R 5 , \u2014CH 2 OPO 3 R 5 R 5 , \u2014CH 2 OPO 3 HR 5 , \u2014CH 2 OPO 3 H 2 \u2014C(\u2550NR 5 )NR 5 R 5 , \u2014NR 5 C(\u2550NR 5 )NR 5 R 5 , \u2014CONH 2 , \u2014CH 2 CONR 5 R 5 , \u2014SR 5 , \u2014SO 3 R 5 , \u2014SO 2 R 5 , \u2014CH 2 NHCOR 5 , \u2014CH 2 NHCNR 5 NR 5 R 5 , \u2014CH 2 COSR 5 , CH 2 NR 5 COR 5 , \u2014CH 2 NR 5 CNR 5 NR 5 R 5 , \u2014CH 2 NR 5 COSR 5 , \u2014CH 2 NHSO 2 R 5 , \u2014CH 2 N R 5 SO 2 R 5 , \u2014CHNR 5 , \u2014CHNOR 5 , \u2014H, \u2014NH 2 , \u2014NHR 5 , \u2014NR 5 R 5 , \u2014OH, \u2014OR 5 , phosphate, \u2014OPO 3 R 5 R 5 , \u2014OPO 3 HR 5 , \u2014OPO 3 H 2 , \u2014NCO, \u2014NCS, \u2014N 3 , \u2014R 5 , \u2014C\u2261CR 5 , \u2014(CH\u2550CH)R 5 , \u2014SH, \u2014SR 5 , \u2014SO 2 H, \u2014SO 3 H, \u2014SO 2 NR 5 R 5 , \u2014SO 3 R 5 , \u2014NHCOR 5 , \u2212, NHCNR 5 NR 5 R 5 , \u2014NHCOSR 5 , secondary amide, tertiary amide, \u2014NR 5 COR 5 , \u2014NR 5 C(\u2550NH)NR 5 R 5 , \u2014NR 5 COSR 5 , \u2014NHC(\u2550NR 5 )R 5 , \u2014NR 5 C(\u2550NR 5 )R 5 , \u2014NHSO 2 (NH 2 ), \u2014NHSO 2 R 5 , \u2014NR 5 SO 2 R 5 , \u2014NR 5 SO 2 NR 5 R 5 , \u2014OCOR 5 , \u2014OCONR 5 R 5 , \u2014O(C\u2550O)OR 5 , \u2014SCOR 5 , \u2014O(C\u2550NH)NR 5 R 5 , \u2014OCSNHR 5 , \u2014OS(\u2550O 2 )R 5 , \u2014OS(\u2550O 2 )NR 5 R 5 , \u2014SCONR 5 R 5 , \u2014CH 2 -aryl, \u2014CH 2 -heteroaryl, R 2  is \u2014H, \u2014CH 3 , \u2014SCH(CH 3 ) 2 , \u2014SC(\u2550O)CH 3 , \u2014SC(\u2550O)R 5 , \u2014SCH 2 CH 2 OCOCH 3 , \u2014SR 5 , \u2014SOR 5 , \u2014SOOR 5 , \u2014SCONR 5 R 5 , R 3  is \u2014OCOCH 3 , \u2014OCOOCH 2 CH 3 , \u2014OR 7 , \u2014R 7 , or \u2014NR 5 R 5  when a double bond is present between C 1  and C 2 , C 3  and C 4 , and C 5  and C 6 ; R 4  is \u2014OCOCH 3 , \u2014OCOOCH 2 CH 3 , \u2014OR 7 , \u2014R 7 , or \u2014NR 5 R 5  when a double bond is present between C 1  and C 2 , C 3  and C 4 , and C 5  and C 6 ; R 3  is O when R 4  is O and a double bond is present between C 2  and R 3  and C 3  and R 4 ; R 4  is \u2014OCH 3 , \u2014OP(\u2550O)(OCH 3 ) 2 , \u2014OH, \u2014OCOOCH 2 CH 3 , \u2014OCONHCH 2 CH 3 , \u2014OCOOCH(CH 3 ) 2 , \u2014OR 7 , \u2014R 7 , or \u2014NR 5 R 5  when R 3  is O and a double bond is present between C 2  and R 3 ; R 3  and R 4  may also be combined to form a heterocylic or carbocyclic ring; R 5  is independently selected for each occurrence hydrogen, an alkyl, cycloalkyl, alkoxy, heterocycloalkyl, alkylaryl, alkenyl, alkynyl, aryl, amine, or heteroaryl, optionally substituted with substituents individually selected from alkyl, alkoxy, cycloalkyl, ether, amine optionally substituted with one or more alkyl, halogen, hydroxyl, ether, cyano, nitrile, CF 3 , ester, amide, cycloalkyl amide, sugar, heteroarylamide optionally substituted with alkyl and/or alkoxy, urea, carbamate, thioether, sulfate, sulfonyl, sulfonic acid carboxylic acid, and aryl or two R 5  groups taken together to form a cycloalkyl, heterocycloalkyl, aryl or heteraryl group, optionally substituted with substituents individually selected from alkyl, cycloalkyl, alkoxy, heterocycloalkyl, alkylaryl, alkenyl, alkynyl, aryl, heteroaryl, amine, halogen, hydroxyl, ether, nitrile, cyano, nitro, CF 3 , ester amide, urea, carbamate, thioether, or carboxylic acid group; and R 7  is hydrogen, an alkyl, cycloalkyl, heterocycloalkyl, alkylaryl, alkenyl, alkynyl, aryl, or heteroaryl, optionally substituted with substituents individually selected from alkyl, cycloalkyl, ether, amine, halogen, hydroxyl, ether, nitrile, cyano, nitrile, CF 3 , ester, amide, urea, carbamate, thioether, or carboxylic acid, or a pharmaceutically acceptable salt or prodrug thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14679846', '14248787', '15263033', '15665755', '13141310']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7962430783131664
- 35 USC 102 Novelty (BERT): 0.5284732536568663
- Combined Prediction Score: 0.7694660958475364
- Mean Citation Score: 301.98621799999995
- Max Citation Score: 317.74167
- Similarity Product: 170.60941757826447

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test